--- title: "RLYB.US (RLYB.US) — Related News" type: "Symbol" locale: "en" url: "https://longbridge.com/en/quote/RLYB.US/news.md" symbol: "RLYB.US" name: "RLYB.US" parent: "https://longbridge.com/en/quote/RLYB.US.md" datetime: "2026-06-10T12:03:43.834Z" locales: - [en](https://longbridge.com/en/quote/RLYB.US/news.md) - [zh-CN](https://longbridge.com/zh-CN/quote/RLYB.US/news.md) - [zh-HK](https://longbridge.com/zh-HK/quote/RLYB.US/news.md) --- # RLYB.US (RLYB.US) — Related News ### [Are SUNE, RLYB, ASRT, TMHC Obtaining Fair Deals for their Shareholders?](https://longbridge.com/en/news/289222291.md) *2026-06-09T17:19:00.000Z* > Halper Sadeh LLC is investigating SUNation Energy, Rallybio, Assertio Holdings, and Taylor Morrison Home for potential b ### [Lixte Biotechnology Shifts Strategy to AI Energy Infrastructure](https://longbridge.com/en/news/288285553.md) *2026-06-01T13:40:47.000Z* > Lixte Biotechnology Holdings (LIXT) announced a strategic pivot from oncology to AI energy infrastructure. The board app ### [](https://longbridge.com/en/news/288289600.md) *2026-06-01T13:42:29.000Z* > This week saw three major deals in rare disease investment: Eli Lilly licensed Hanmi's GLP-2 therapy sonefpeglutide for ### [Insider Buying: Rallybio (NASDAQ:RLYB) Major Shareholder Buys 10,200 Shares of Stock](https://longbridge.com/en/news/287138492.md) *2026-05-21T01:17:20.000Z* > Adar1 Capital Management, a major shareholder of Rallybio Corporation (NASDAQ:RLYB), purchased 10,200 shares at $13.98 e ### [Rallybio (NASDAQ:RLYB) Major Shareholder Adar1 Capital Management, Llc Acquires 800 Shares](https://longbridge.com/en/news/286420443.md) *2026-05-14T12:52:45.000Z* > Rallybio Corporation's major shareholder, Adar1 Capital Management, acquired 800 shares at $13.83 each, totaling $11,064 ### [Rallybio | 10-Q: FY2026 Q1 Revenue Beats Estimate at USD 212 K](https://longbridge.com/en/news/286309570.md) *2026-05-13T20:08:44.000Z* ### [Rallybio (RLYB) Projected to Post Quarterly Earnings on Tuesday](https://longbridge.com/en/news/285242746.md) *2026-05-05T17:07:41.000Z* > Rallybio (NASDAQ:RLYB) is set to announce its Q1 2026 earnings on May 12, with analysts predicting a loss of $1.20 per s